Virtus Biotech ETF
7 hedge funds and large institutions have $1.02M invested in Virtus Biotech ETF in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
250% more funds holding
Funds holding: 2 → 7 (+5)
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
48% less capital invested
Capital invested by funds: $1.96M → $1.02M (-$938K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$444K |
| 2 |
LPL Financial
San Diego,
California
|
+$397K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$58.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$34.5K |
| 5 |
FWM
Focused Wealth Management
Newburgh,
New York
|
+$17.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.96M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
1
Credit Suisse
Zurich,
Switzerland
| $470K | +$444K | +15,151 | New |
|
|
2
LPL Financial
San Diego,
California
| $423K | +$397K | +13,544 | New |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $62K | +$58.6K | +2,000 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $37K | +$34.5K | +1,179 | New |
|
|
FWM
5
Focused Wealth Management
Newburgh,
New York
| $19K | +$17.6K | +600 | New |
|
6
Creative Planning
Overland Park,
Kansas
| $6K | +$5.86K | +200 | New |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| $5K | +$4.92K | +168 | New |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1.96M | -75,000 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$1K | -38 | Closed |
|
BBP Hedge Fund Activity: Q1 2015 in Review
7 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q1 2015, worth a combined $1.02M — down 48% from $1.96M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BBP positions and 2 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Credit Suisse, opening a new position worth an estimated $444K. The largest seller was Deutsche Bank, exiting entirely with an estimated $1.96M sold.
- 7 institutional investors held Virtus Biotech ETF (BBP) as of Q1 2015, up from 2 in Q4 2014.
- Funds reported $1.02M of Virtus Biotech ETF stock for Q1 2015, down 48% quarter-over-quarter.
- 7 funds opened new Virtus Biotech ETF positions in Q1 2015 and 2 closed out, a net change of +5 holders.
- The largest Virtus Biotech ETF buyer in Q1 2015 was Credit Suisse, an estimated $444K added.
- The largest Virtus Biotech ETF seller in Q1 2015 was Deutsche Bank, an estimated $1.96M sold.
Based on aggregated 13F filings for Q1 2015.